SCHEMBL23733168

SCHEMBL23733168

COC(=O)C(=O)OC1=CC(=O)SC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23733074 0.91
SCHEMBL23732621 0.81
SCHEMBL23733167 0.78 SMN1; SMN2 (0.37)
SCHEMBL23732622 0.73 MAPT (0.34)
SCHEMBL23732629 0.71 HTT (0.39)
SCHEMBL23732671 0.65
SCHEMBL23733147 0.63 MAPT (0.34)
SCHEMBL23732628 0.61
SCHEMBL6950834 0.60 ALDH1A1 (0.56)
SCHEMBL8295 0.60

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210238155-A1 CARBON MONOXIDE PRODRUGS FOR THE TREATMENT OF MEDICAL DISORDERS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION, INC. (US) 2021-08-05 US disclosed